bloating after stopping glp 1 What Happens When You Stop GLP-1s — And How to Prevent Weight Regain GLP-1 nausea: How to handle

Financial Times reported this week that Lilly and Novo, the manufacturers of all four GLP-1 drugs commonly used for obesity therapy, are spending $3.5 billion this year to purchase smaller companies with promising anti-obesity therapies

Trial Evidence Supporting Early AOM Use Recent clinical trials demonstrate the effectiveness of early anti-obesity medication (AOM) intervention for patients showing minimal response to behavioral therapy (BT) alone

Glutamate and schizophrenia: beyond the dopamine hypothesis

Real numbers tell the story: Studies show that women with obesity who lose just 5-10% of body weight see a 50% improvement in ovulation rates, a 30% improvement in natural conception rates, and restoration of regular cycles in 60-70% of women with irregular periods

Tirzepatide stimulates insulin secretion through the GIPR in human islets from healthy donors, supporting a role for GIPR agonism in its pharmacology (56)